Next Article in Journal
Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients
Previous Article in Journal
Diffusion Kurtosis Imaging—A Superior Approach to Assess Tumor–Stroma Ratio in Pancreatic Ductal Adenocarcinoma
Previous Article in Special Issue
Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy
Open AccessReview

Two-Dimensional Theranostic Nanomaterials in Cancer Treatment: State of the Art and Perspectives

1
BIO-IT Foundry Technology Institute, Pusan National University, Busan 46241, Korea
2
Department of Cogno-Mechatronics Engineering, College of Nanoscience & Nanotechnology, Pusan National University, Busan 46241, Korea
3
Department of Organic Materials Science and Engineering, College of Engineering, Pusan National University, Busan 46241, Korea
4
Research Centre for Advanced Specialty Chemicals, Division of Specialty and Bio-based Chemicals Technology, Korea Research Institute of Chemical Technology (KRICT), Ulsan 44412, Korea
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this paper.
Cancers 2020, 12(6), 1657; https://doi.org/10.3390/cancers12061657
Received: 13 May 2020 / Revised: 11 June 2020 / Accepted: 17 June 2020 / Published: 22 June 2020
As the combination of therapies enhances the performance of biocompatible materials in cancer treatment, theranostic therapies are attracting increasing attention rather than individual approaches. In this review, we describe a variety of two-dimensional (2D) theranostic nanomaterials and their efficacy in ablating tumors. Though many literature reports are available to demonstrate the potential application of 2D nanomaterials, we have reviewed here cancer-treating therapies based on such multifunctional nanomaterials abstracting the content from literature works which explain both the in vitro and in vivo level of applications. In addition, we have included a discussion about the future direction of 2D nanomaterials in the field of theranostic cancer treatment. View Full-Text
Keywords: two-dimensional nanomaterials; cancer theranostics; tumor; biomedical imaging; in vitro and in vivo biological applications two-dimensional nanomaterials; cancer theranostics; tumor; biomedical imaging; in vitro and in vivo biological applications
Show Figures

Figure 1

MDPI and ACS Style

Raja, I.S.; Kang, M.S.; Kim, K.S.; Jung, Y.J.; Han, D.-W. Two-Dimensional Theranostic Nanomaterials in Cancer Treatment: State of the Art and Perspectives. Cancers 2020, 12, 1657.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop